Cargando…
HIV-Infected Individuals Who Delay, Decline, or Discontinue Antiretroviral Therapy: Comparing Clinic- and Peer-Recruited Cohorts
A substantial proportion of persons living with HIV/AIDS (PLHA) delay, decline, or discontinue antiretroviral therapy (ART) when it is medically indicated (40–45%), largely African-Americans and Latinos/Hispanics. This study explores the feasibility of locating PLHA, who are not on ART (PLHA-NOA) th...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4100062/ https://www.ncbi.nlm.nih.gov/pubmed/25077137 http://dx.doi.org/10.3389/fpubh.2014.00081 |
_version_ | 1782326606167015424 |
---|---|
author | Gwadz, Marya Applegate, Elizabeth Cleland, Charles Leonard, Noelle Regina Wolfe, Hannah Salomon, Nadim Belkin, Mindy Riedel, Marion Banfield, Angela Sanfilippo, Lisa Wagner, Andrea Mildvan, Donna |
author_facet | Gwadz, Marya Applegate, Elizabeth Cleland, Charles Leonard, Noelle Regina Wolfe, Hannah Salomon, Nadim Belkin, Mindy Riedel, Marion Banfield, Angela Sanfilippo, Lisa Wagner, Andrea Mildvan, Donna |
author_sort | Gwadz, Marya |
collection | PubMed |
description | A substantial proportion of persons living with HIV/AIDS (PLHA) delay, decline, or discontinue antiretroviral therapy (ART) when it is medically indicated (40–45%), largely African-Americans and Latinos/Hispanics. This study explores the feasibility of locating PLHA, who are not on ART (PLHA-NOA) through clinics and peer-referral; compares the two cohorts on multi-level barriers to ART; and examines readiness to initiate/reinitiate ART, a predictor of treatment outcomes. We recruited adult HIV-infected African-American and Latino/Hispanic PLHA-NOA through HIV hospital clinics and peer-referral in 2012–2013. Participants were engaged in structured 1-h assessments with reliable/valid measures on barriers to ART. We found that recruitment through peers (63.2%, 60/95) was more feasible than in clinics (36.8%, 35/90). Participants were 48.0 years old and had lived with HIV for 14.7 years on average, and 56.8% had taken ART previously. Most (61.1%) were male and African-American (76.8%), and 23.2% were Latino/Hispanic. Peer-recruited participants were older, had lived with HIV longer, were less engaged in HIV care, and were more likely to have taken ART previously. The cohorts differed in reasons for discontinuing ART. Levels of ART knowledge were comparable between cohorts (68.5% correct), and there were no differences in attitudes toward ART (e.g., mistrust), which were in the neutral range. In bivariate linear regression, readiness for ART was negatively associated with physician mistrust (B = −10.4) and positively associated with self-efficacy (B = 5.5), positive outcome expectancies (B = 6.3), beliefs about personal necessity of ART (B = 17.5), and positive internal norms (B = 7.9). This study demonstrates the feasibility of engaging this vulnerable population through peer-referral. Peer-recruited PLHA evidence particularly high rates of risk factors compared to those in hospital clinics. Interventions to support ART initiation and continuation are sorely needed for both subgroups. |
format | Online Article Text |
id | pubmed-4100062 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-41000622014-07-30 HIV-Infected Individuals Who Delay, Decline, or Discontinue Antiretroviral Therapy: Comparing Clinic- and Peer-Recruited Cohorts Gwadz, Marya Applegate, Elizabeth Cleland, Charles Leonard, Noelle Regina Wolfe, Hannah Salomon, Nadim Belkin, Mindy Riedel, Marion Banfield, Angela Sanfilippo, Lisa Wagner, Andrea Mildvan, Donna Front Public Health Public Health A substantial proportion of persons living with HIV/AIDS (PLHA) delay, decline, or discontinue antiretroviral therapy (ART) when it is medically indicated (40–45%), largely African-Americans and Latinos/Hispanics. This study explores the feasibility of locating PLHA, who are not on ART (PLHA-NOA) through clinics and peer-referral; compares the two cohorts on multi-level barriers to ART; and examines readiness to initiate/reinitiate ART, a predictor of treatment outcomes. We recruited adult HIV-infected African-American and Latino/Hispanic PLHA-NOA through HIV hospital clinics and peer-referral in 2012–2013. Participants were engaged in structured 1-h assessments with reliable/valid measures on barriers to ART. We found that recruitment through peers (63.2%, 60/95) was more feasible than in clinics (36.8%, 35/90). Participants were 48.0 years old and had lived with HIV for 14.7 years on average, and 56.8% had taken ART previously. Most (61.1%) were male and African-American (76.8%), and 23.2% were Latino/Hispanic. Peer-recruited participants were older, had lived with HIV longer, were less engaged in HIV care, and were more likely to have taken ART previously. The cohorts differed in reasons for discontinuing ART. Levels of ART knowledge were comparable between cohorts (68.5% correct), and there were no differences in attitudes toward ART (e.g., mistrust), which were in the neutral range. In bivariate linear regression, readiness for ART was negatively associated with physician mistrust (B = −10.4) and positively associated with self-efficacy (B = 5.5), positive outcome expectancies (B = 6.3), beliefs about personal necessity of ART (B = 17.5), and positive internal norms (B = 7.9). This study demonstrates the feasibility of engaging this vulnerable population through peer-referral. Peer-recruited PLHA evidence particularly high rates of risk factors compared to those in hospital clinics. Interventions to support ART initiation and continuation are sorely needed for both subgroups. Frontiers Media S.A. 2014-07-16 /pmc/articles/PMC4100062/ /pubmed/25077137 http://dx.doi.org/10.3389/fpubh.2014.00081 Text en Copyright © 2014 Gwadz, Applegate, Cleland, Leonard, Wolfe, Salomon, Belkin, Riedel, Banfield, Sanfilippo, Wagner, Mildvan and The Heart to Heart Collaborative Research Team. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Public Health Gwadz, Marya Applegate, Elizabeth Cleland, Charles Leonard, Noelle Regina Wolfe, Hannah Salomon, Nadim Belkin, Mindy Riedel, Marion Banfield, Angela Sanfilippo, Lisa Wagner, Andrea Mildvan, Donna HIV-Infected Individuals Who Delay, Decline, or Discontinue Antiretroviral Therapy: Comparing Clinic- and Peer-Recruited Cohorts |
title | HIV-Infected Individuals Who Delay, Decline, or Discontinue Antiretroviral Therapy: Comparing Clinic- and Peer-Recruited Cohorts |
title_full | HIV-Infected Individuals Who Delay, Decline, or Discontinue Antiretroviral Therapy: Comparing Clinic- and Peer-Recruited Cohorts |
title_fullStr | HIV-Infected Individuals Who Delay, Decline, or Discontinue Antiretroviral Therapy: Comparing Clinic- and Peer-Recruited Cohorts |
title_full_unstemmed | HIV-Infected Individuals Who Delay, Decline, or Discontinue Antiretroviral Therapy: Comparing Clinic- and Peer-Recruited Cohorts |
title_short | HIV-Infected Individuals Who Delay, Decline, or Discontinue Antiretroviral Therapy: Comparing Clinic- and Peer-Recruited Cohorts |
title_sort | hiv-infected individuals who delay, decline, or discontinue antiretroviral therapy: comparing clinic- and peer-recruited cohorts |
topic | Public Health |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4100062/ https://www.ncbi.nlm.nih.gov/pubmed/25077137 http://dx.doi.org/10.3389/fpubh.2014.00081 |
work_keys_str_mv | AT gwadzmarya hivinfectedindividualswhodelaydeclineordiscontinueantiretroviraltherapycomparingclinicandpeerrecruitedcohorts AT applegateelizabeth hivinfectedindividualswhodelaydeclineordiscontinueantiretroviraltherapycomparingclinicandpeerrecruitedcohorts AT clelandcharles hivinfectedindividualswhodelaydeclineordiscontinueantiretroviraltherapycomparingclinicandpeerrecruitedcohorts AT leonardnoelleregina hivinfectedindividualswhodelaydeclineordiscontinueantiretroviraltherapycomparingclinicandpeerrecruitedcohorts AT wolfehannah hivinfectedindividualswhodelaydeclineordiscontinueantiretroviraltherapycomparingclinicandpeerrecruitedcohorts AT salomonnadim hivinfectedindividualswhodelaydeclineordiscontinueantiretroviraltherapycomparingclinicandpeerrecruitedcohorts AT belkinmindy hivinfectedindividualswhodelaydeclineordiscontinueantiretroviraltherapycomparingclinicandpeerrecruitedcohorts AT riedelmarion hivinfectedindividualswhodelaydeclineordiscontinueantiretroviraltherapycomparingclinicandpeerrecruitedcohorts AT banfieldangela hivinfectedindividualswhodelaydeclineordiscontinueantiretroviraltherapycomparingclinicandpeerrecruitedcohorts AT sanfilippolisa hivinfectedindividualswhodelaydeclineordiscontinueantiretroviraltherapycomparingclinicandpeerrecruitedcohorts AT wagnerandrea hivinfectedindividualswhodelaydeclineordiscontinueantiretroviraltherapycomparingclinicandpeerrecruitedcohorts AT mildvandonna hivinfectedindividualswhodelaydeclineordiscontinueantiretroviraltherapycomparingclinicandpeerrecruitedcohorts AT hivinfectedindividualswhodelaydeclineordiscontinueantiretroviraltherapycomparingclinicandpeerrecruitedcohorts |